320 likes | 576 Views
2. Academic detailing. Pharmaco-epistemologyHow do we know what we know about drugs?Educating physiciansUnderstanding effective learningAcademic detailingHistory and researchCurrent programsEncouraging signs and new opportunities. 2. 3. The problem. Limited data when drugs first approved
E N D
1. Michael Fischer, M.D., M.S. Division of Pharmacoepidemiology & Pharmacoeconomics Brigham & Women’s Hospital Harvard Medical School Independent Drug Information Service Alosa Foundation